Company
Investment-firm
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Contacts
Similar Companies999
Quan Capital
Quan Capital is a healthcare-focused venture capital firm.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Bold Capital Partners
Bold Capital Partners invests in early-stage life sciences, healthcare, and frontier tech companies.
Sector
Subsector
Keywords
Location
total rounds
count Of Investments
count Of Exists
F-Prime Capital
F-Prime Capital is a venture capital firm that invests in technology, healthcare and life sciences sectors in the United States and Europe.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Radius Ventures
Radius Ventures is a VC firm that invests in health and life science companies.
Sector
Subsector
Location
count Of Investments
count Of Exists
Financials
Investments59
Medii
Medii app provides on-site consulting to medical institutions in underserved regions.
Sector
Subsector
Keywords
Location
total rounds
A10 Lab
A10 Lab develops a self-improvement mobile application for behavior change.
Sector
Subsector
Keywords
Location
total rounds
total raised
Shinobi Therapeutics
Shinobi Therapeutics is a biotechnology business that is working on a novel class of immune-evasive iPSC-derived cell treatments.
total rounds
total raised
Co-Investors
Exits3
Mentalhealth Technologies
Mentalhealth Technologies offers mental health solutions to businesses.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
Japan Medical Information Research Institute
JMIRI provides prescription data and analysis to Japanese pharmaceutical companies.
Sector
Subsector
Keywords
Location
total rounds
count Of Investments
ProbeX
The company provides molecular imaging probe reagents for drug discovery.
Sector
Subsector
Keywords
Location
total rounds
People
Founders1
Hiromichi Kimura
Dr. Hiromichi Kimura is the founder, CEO, and a Managing Partner of FTI and a recognized leader in the Japanese biotech and pharmaceutical industry. With years of industry experience in top management, he has implemented numerous external collaborations and innovations. In addition to his career in venture capital, he directs academic studies in the field of innovation management and lifestyle design and biotechnology incubations with the Kawasaki city local government. After Hiromichi’s successful career at Kyowa Hakko Kogyo (presently known as Kyowa Kirin) in its clinical research division and at JP Morgan in Financial Advisory and M&A, he joined Pharmacia (formerly known as Amersham Pharmacia Biotech before being acquired by GE Healthcare) where he eventually became the President and Representative Director. He was also the President and Representative Director of Monsanto Japan (currently Pfizer Japan) and served as the CEO of HuBit Genomix. Hiromichi has held academia positions as professor at the University of Tokyo and is currently a Project Professor at the University of Tokyo Institute for Future Initiatives (IFI). He is also the Deputy Chairman at Stanford Alumni Association Japan.
Hiromichi Kimura
